Payer+Provider's Health System Review
November 25, 2020
The American Telemedicine Association said the newly released final rules move the healthcare industry closer to a value-based care model.
November 24, 2020
Risk adjustment data validation ensures payment integrity and accuracy and it affects what plans are paid.
Barring an appeals court decision overturning the rule, the mandate goes into effect on January 1, 2021.
PhRMA questions the cost savings and says the rule leaves safety considerations to state governments, rather than the required federal oversight.
November 23, 2020
The treatment will be available at no cost to patients, although healthcare facilities may charge for the administration.
The interim rule would cut drug reimbursements to hospitals by an average of 65% when fully phased in, the AHA says.
November 21, 2020
The old federal regulations burdened providers with added administrative costs and fear of financial consequences, CMS says.
Opponents say the rule will not lower drug prices and some question whether it is legal, having bypassed the public comment process.
November 20, 2020
The letter warns that the new thresholds are too high and will force many clinicians to exit from APMs and revert back to fee-for-service.